Novel astatine (211At)-labelled prostate-specific membrane antigen ligand with a neopentyl-glycol structure: evaluation of stability, efficacy, and safety using a prostate cancer xenograft model.
Yaginuma K, Takahashi K, Hoshi S, Joho T, Shimoyama S, Hasegawa N, Hasegawa K, Zhao S, Ukon N, Makabe S, Meguro S, Onagi A, Matsuoka K, Ogawa S, Uemura M, Yamashita T, Suzuki H, Uehara T, Kojima Y.
Yaginuma K, et al. Among authors: takahashi k.
Eur J Nucl Med Mol Imaging. 2024 Oct 12. doi: 10.1007/s00259-024-06945-x. Online ahead of print.
Eur J Nucl Med Mol Imaging. 2024.
PMID: 39394527